Halozyme Therapeutics (HALO) Gross Margin Growth (5y) (2015 - 2026)
Halozyme Therapeutics (HALO) Gross Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Halozyme Therapeutics | 9.55 Bn | 9.23 Bn | 297.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.00 |
| Dec 31, 2025 | 415.00 |
| Sep 30, 2025 | -707.00 |
| Jun 30, 2025 | -384.00 |
| Mar 31, 2025 | 455.00 |
| Dec 31, 2024 | 1,698.00 |
| Sep 30, 2024 | 3,127.00 |
| Jun 30, 2024 | -1,233.00 |
| Mar 31, 2024 | -630.00 |
| Dec 31, 2023 | -1,340.00 |
| Sep 30, 2023 | -2,293.00 |
| Jun 30, 2023 | -2,028.00 |
| Mar 31, 2023 | -1,180.00 |
| Dec 31, 2022 | -1,926.00 |
| Sep 30, 2022 | -957.00 |
| Jun 30, 2022 | 80.00 |
| Mar 31, 2022 | 1,194.00 |
| Dec 31, 2021 | -65.00 |
| Sep 30, 2021 | 1,263.00 |
| Jun 30, 2021 | 805.00 |